{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:37:06Z","timestamp":1790242626967,"version":"4.1.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6,1]]},"DOI":"10.1095\/biolreprod.113.114165","type":"journal-article","created":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T22:48:41Z","timestamp":1397688521000},"source":"Crossref","is-referenced-by-count":45,"title":["Treatment with Bazedoxifene and Conjugated Estrogens Results in Regression of Endometriosis in a Murine Model1"],"prefix":"10.1093","volume":"90","author":[{"given":"Hanyia","family":"Naqvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharif","family":"Sakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Presti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Krikun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Komm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh S.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"issue":"(9447)","key":"key\n\t\t\t\t20170224030917_R01","first-page":"1789","article-title":"Endometriosis","volume":"364","year":"2004","journal-title":"Lancet"},{"issue":"(3)","key":"key\n\t\t\t\t20170224030917_R02","first-page":"268","article-title":"Endometriosis","volume":"360","year":"2009","journal-title":"N Engl J Med"},{"issue":"(1)","key":"key\n\t\t\t\t20170224030917_R03","first-page":"130","article-title":"Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer","volume":"34","year":"2013","journal-title":"Endocr Rev"},{"issue":"(4)","key":"key\n\t\t\t\t20170224030917_R04","first-page":"419","article-title":"Role of eutopic endometrium in pelvic endometriosis","volume":"18","year":"2011","journal-title":"J Minim Invasive Gynecol"},{"key":"key\n\t\t\t\t20170224030917_R05","article-title":"Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20170224030917_R06","article-title":"Hormone therapy for endometriosis and surgical menopause","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20170224030917_R07","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1471-0528.2008.01740.x","article-title":"Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis","volume":"115","year":"2008","journal-title":"BJOG"},{"key":"key\n\t\t\t\t20170224030917_R08","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1517\/14656566.9.2.243","article-title":"Treatment strategies for endometriosis","volume":"9","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"key\n\t\t\t\t20170224030917_R09","article-title":"Modern combined oral contraceptives for pain associated with endometriosis","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"(4)","key":"key\n\t\t\t\t20170224030917_R10","first-page":"283","article-title":"Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?","volume":"22","year":"2010","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"(4)","key":"key\n\t\t\t\t20170224030917_R11","first-page":"287","article-title":"The use of gonadotropin releasing hormone analogues in adolescent and young patients with endometriosis","volume":"25","year":"2013","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"(3)","key":"key\n\t\t\t\t20170224030917_R12","first-page":"609","article-title":"Designing the ideal selective estrogen receptor modulator\u2014an achievable goal?","volume":"16","year":"2009","journal-title":"Menopause"},{"key":"key\n\t\t\t\t20170224030917_R13","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJMra022219","article-title":"Selective estrogen receptor modulators\u2014mechanisms of action and application to clinical practice","volume":"348","year":"2003","journal-title":"N Engl J Med"},{"issue":"(9880)","key":"key\n\t\t\t\t20170224030917_R14","first-page":"1827","article-title":"Chemoprevention of Breast Cancer Overview Group. Selective estrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data","volume":"381","year":"2013","journal-title":"Lancet"},{"issue":"(3)","key":"key\n\t\t\t\t20170224030917_R15","first-page":"642","article-title":"Endometrial safety: a key hurdle for selective estrogen receptor modulators in development","volume":"17","year":"2010","journal-title":"Menopause"},{"issue":"(7)","key":"key\n\t\t\t\t20170224030917_R16","first-page":"777","article-title":"Endometrial profile of bazedoxifene acetate alone and in combination with conjugated equine estrogens in a primate model","volume":"20","year":"2013","journal-title":"Menopause"},{"issue":"(6)","key":"key\n\t\t\t\t20170224030917_R17","first-page":"1109","article-title":"Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women","volume":"16","year":"2009","journal-title":"Menopause"},{"issue":"(7)","key":"key\n\t\t\t\t20170224030917_R18","first-page":"847","article-title":"Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial","volume":"287","year":"2002","journal-title":"JAMA"},{"issue":"(8)","key":"key\n\t\t\t\t20170224030917_R19","first-page":"3609","article-title":"Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial","volume":"87","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170224030917_R20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1749-6632.1995.tb31392.x","article-title":"Raloxifene is a tissue-selective agonist\/antagonist that functions through the estrogen receptor","volume":"761","year":"1995","journal-title":"Ann N Y Acad Sci"},{"issue":"(1)","key":"key\n\t\t\t\t20170224030917_R21","first-page":"45","article-title":"Selective estrogen receptor modulators: an alternative to hormone replacement therapy","volume":"217","year":"1998","journal-title":"Proc Soc Exp Biol Med"},{"issue":"(23)","key":"key\n\t\t\t\t20170224030917_R22","first-page":"2727","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","year":"2006","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170224030917_R23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1172\/JCI116985","article-title":"Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats","volume":"93","year":"1994","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170224030917_R24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/08941930591004412","article-title":"Validation of rat endometriosis model by using raloxifene as a positive control for the evaluation of novel SERM compounds","volume":"18","year":"2005","journal-title":"J Invest Surg"},{"key":"key\n\t\t\t\t20170224030917_R25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/01.AOG.0000297307.35024.b5","article-title":"Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial","volume":"111","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"(2)","key":"key\n\t\t\t\t20170224030917_R26","first-page":"44","article-title":"Bazedoxifene: a new selective estrogen receptor modulator for postmenopausal osteoporosis","volume":"17","year":"2011","journal-title":"Menopause Int"},{"key":"key\n\t\t\t\t20170224030917_R27","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.fertnstert.2009.05.094","article-title":"Endometrial effects of a tissue selective estrogen complex containing bazedoxifene\/conjugated estrogens as a menopausal therapy","volume":"92","year":"2009","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170224030917_R28","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/gme.0b013e3181a816be","article-title":"Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis","volume":"16","year":"2009","journal-title":"Menopause"},{"issue":"(4)","key":"key\n\t\t\t\t20170224030917_R29","first-page":"329","article-title":"Bazedoxifene\/conjugated estrogens and quality of life in postmenopausal women","volume":"63","year":"2009","journal-title":"Maturitas"},{"issue":"(6)","key":"key\n\t\t\t\t20170224030917_R30","first-page":"1116","article-title":"Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene\/conjugated estrogens: a randomized, controlled trial","volume":"16","year":"2009","journal-title":"Menopause"},{"issue":"(3 pt 1)","key":"key\n\t\t\t\t20170224030917_R31","first-page":"510","article-title":"The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety","volume":"14","year":"2007","journal-title":"Menopause"},{"key":"key\n\t\t\t\t20170224030917_R32","first-page":"4244S","article-title":"Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors","volume":"46","year":"1986","journal-title":"Cancer Res"},{"issue":"(4)","key":"key\n\t\t\t\t20170224030917_R33","first-page":"266","article-title":"Treatment of endometriosis","volume":"345","year":"2001","journal-title":"N Engl J Med"},{"issue":"(9)","key":"key\n\t\t\t\t20170224030917_R34","first-page":"814","article-title":"Novel therapies targeting endometriosis","volume":"18","year":"2011","journal-title":"Reprod Sci"},{"issue":"(4)","key":"key\n\t\t\t\t20170224030917_R35","first-page":"535","article-title":"Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility","volume":"39","year":"2012","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"(6)","key":"key\n\t\t\t\t20170224030917_R36","first-page":"563","article-title":"The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis","volume":"19","year":"2012","journal-title":"Reprod Sci"},{"issue":"(1)","key":"key\n\t\t\t\t20170224030917_R37","first-page":"16","article-title":"Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study","volume":"91","year":"1998","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t20170224030917_R38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0889-8545(02)00057-8","article-title":"Medical management of endometriosis-associated pain","volume":"30","year":"2003","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"(1)","key":"key\n\t\t\t\t20170224030917_R39","first-page":"167","article-title":"Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment","volume":"285","year":"2012","journal-title":"Arch Gynecol Obstet"},{"issue":"(6)","key":"key\n\t\t\t\t20170224030917_R40","first-page":"649","article-title":"Endometriosis","volume":"69","year":"2009","journal-title":"Drugs"},{"issue":"(5)","key":"key\n\t\t\t\t20170224030917_R41","first-page":"483","article-title":"On etiology or lack of understanding: defining future directions for endometriosis research: workshop report from the 2011 World Congress of Endometriosis in Montpellier, France","volume":"20","year":"2013","journal-title":"Reprod Sci"},{"issue":"(8)","key":"key\n\t\t\t\t20170224030917_R42","first-page":"3226","article-title":"Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model","volume":"152","year":"2011","journal-title":"Endocrinology"},{"issue":"(3)","key":"key\n\t\t\t\t20170224030917_R43","first-page":"338","article-title":"Effects of bazedoxifene\/conjugated estrogens on endometrial safety and bone in postmenopausal women","volume":"16","year":"2013","journal-title":"Climacteric"},{"issue":"(4)","key":"key\n\t\t\t\t20170224030917_R44","first-page":"479","article-title":"Using bazedoxifene plus conjugated estrogens for treating postmenopausal women: a comprehensive review","volume":"19","year":"2012","journal-title":"Menopause"},{"key":"key\n\t\t\t\t20170224030917_R45","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/13697137.2012.696289","article-title":"Bazedoxifene\/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention","volume":"15","year":"2012","journal-title":"Climacteric"},{"key":"key\n\t\t\t\t20170224030917_R46","first-page":"129","article-title":"Incorporating bazedoxifene\/conjugated estrogens into the current paradigm of menopausal therapy","volume":"4","year":"2012","journal-title":"Int J Womens Health"},{"issue":"(1)","key":"key\n\t\t\t\t20170224030917_R47","first-page":"74","article-title":"Differential biochemical and cellular actions of Premarin estrogens: distinct pharmacology of bazedoxifene-conjugated estrogens combination","volume":"23","year":"2009","journal-title":"Mol Endocrinol"},{"issue":"(9)","key":"key\n\t\t\t\t20170224030917_R48","first-page":"2420","article-title":"Bazedoxifene exhibits antiestrogenic activity in animal models of tamoxifen-resistant breast cancer: implications for treatment of advanced disease","volume":"19","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"(2)","key":"key\n\t\t\t\t20170224030917_R49","first-page":"129","article-title":"Tissue selective estrogen complexes (TSECs) differentially modulate markers of proliferation and differentiation in endometrial cells","volume":"20","year":"2013","journal-title":"Reprod Sci"}],"container-title":["Biology of Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/biolreprod\/article-pdf\/90\/6\/121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T07:01:12Z","timestamp":1503558072000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biolreprod\/article-lookup\/doi\/10.1095\/biolreprod.113.114165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,1]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6,1]]}},"URL":"https:\/\/doi.org\/10.1095\/biolreprod.113.114165","relation":{},"ISSN":["0006-3363","1529-7268"],"issn-type":[{"value":"0006-3363","type":"print"},{"value":"1529-7268","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,1]]}}}